Combined oral contraceptives linked to higher risk of irritable bowel syndrome (IBS)

Credit: Unsplash+.

A study presented at the annual meeting of the American College of Gastroenterology has revealed a potential link between the use of combined oral contraceptives (COCs) and a higher risk of developing irritable bowel syndrome (IBS).

IBS is a common gastrointestinal disorder characterized by symptoms such as abdominal pain, bloating, and changes in bowel habits.

Understanding the relationship between COCs and IBS is essential for women’s health.

The Study: Assessing COCs and IBS Risk

Researchers, including Yuhan Fu, D.O., from the University of Louisville, and Gengqing Song, M.D., from Case Western Reserve University, conducted an analysis involving 54,645 female patients aged 15 to 45 years who were prescribed COCs before 2018.

This group was compared to a control group of 54,645 patients who had copper intrauterine devices inserted before 2018.

The goal was to determine if there was an association between COC use and the risk of developing IBS.

Key Findings: COCs and IBS Risk

Over a five-year period, the study found that patients prescribed COCs had a higher risk of developing new-onset IBS. The odds ratio (OR) ranged from 1.34 to 1.71, indicating an increased risk.

Furthermore, when IBS was categorized into its subtypes, COC users were found to have higher risks for developing IBS with predominant constipation, IBS with predominant diarrhea and IBS with mixed bowel habits.

Discussion: Exploring the Role of COCs and Hormones

The study’s findings suggest a potential association between COC use and an elevated risk of IBS and its subtypes. However, it’s important to note that this study establishes a correlation and not causation.

Further research is needed to delve into the mechanisms behind this link and understand how estrogen and progesterone, the hormones in COCs, may contribute to the development and progression of IBS.

Conclusion: A Call for Further Investigation

This study highlights the need for continued research into the potential connection between COCs and the risk of IBS.

As COCs are widely used by many women for contraception, understanding any associated health risks is crucial for informed decision-making and women’s overall well-being.

Further studies will help shed light on the complex relationship between hormonal contraceptives and gastrointestinal health.

If you care about nutrition, please read studies about berry that can prevent cancer, diabetes, and obesity, and the harm of vitamin D deficiency you need to know.

For more information about nutrition, please see recent studies about the connection between potatoes and high blood pressure,  and results showing why turmeric is a health game-changer.

Follow us on Twitter for more articles about this topic.

Copyright © 2023 Knowridge Science Report. All rights reserved.